• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Nebius Group N.V.

    6/5/25 4:01:17 PM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology
    Get the next $NBIS alert in real time by email
    6-K 1 tm2517269d1_6k.htm FORM 6-K

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 6-K

     

    Report of Foreign Private Issuer

    Pursuant to Rule 13a-16 or 15d-16 of

    the Securities Exchange Act of 1934

     

    June 5, 2025

     

    NEBIUS GROUP N.V.

     

    Schiphol Boulevard 165

    1118 BG, Schiphol, the Netherlands.

    Tel: +31 202 066 970

    (Address, Including ZIP Code, and Telephone Number,

    Including Area Code, of Registrant’s Principal Executive Offices)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     

    Form 20-F x        Form 40-F ¨

     

     

     

     

     

     

    INTRODUCTION

     

    As previously announced, on June 2, 2025, Nebius Group N.V. (the “Company”) entered into subscription agreements (the “Subscription Agreements”) with the investors named therein (the “Investors”), for the private placement (the “Private Placement”) of senior unsecured convertible notes in an aggregate principal amount of $1 billion, in two tranches: $500,000,000 aggregate principal amount of 2.00% convertible notes due 2029 (the “2029 Notes”), and $500,000,000 aggregate principal amount of 3.00% convertible notes due 2031 (the “2031 Notes” and, together with the 2029 Notes, the “Notes”). The Private Placement transaction closed on June 5, 2025 and the Notes have been issued.

     

    The Company intends to use the net proceeds of the issuance of the Notes to support finance the continuing growth of its business, including the acquisition of additional compute power, the expansion of its data center footprint, and for general corporate purposes.

     

    THE NOTES

     

    The Notes have been issued pursuant to respective indentures dated June 5, 2025 (the “Indentures”) between the Company and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”). The Notes are senior, unsecured obligations of the Company and bear interest on the original principal amount thereof at an annual rate of 2.00%, in the case of the 2029 Notes, and 3.00%, in the case of the 2031 Notes, payable semi-annually in arrears on June 5 and December 5, beginning on December 5, 2025. The Notes will mature on June 5, 2029 and June 5, 2031, respectively, unless earlier redeemed, repurchased or converted in accordance with their terms prior to such dates.

     

    The original principal amount of the Notes plus an amount accreted thereon (together, the “Accreted Principal Amount”) will be payable on the respective maturity date and upon an event of default (as defined in the respective Indentures), unless the relevant Notes have been earlier repurchased, redeemed or converted in accordance with their terms. The Accreted Principal Amount shall be calculated in accordance with an accretion schedule included in the respective Indentures, such that it reaches 120% of the original principal amount of the 2029 Notes and 125% of the original principal amount of the 2031 Notes on the respective maturity dates.

     

    The Notes have an initial conversion rate of 19.4363 Class A ordinary shares of the Company per $1,000 original principal amount of the Notes, which is equivalent to an initial conversion price of approximately $51.45 per Class A ordinary share, representing an initial conversion premium of approximately 40% over the last reported sale price of the Company’s Class A ordinary shares on the Nasdaq Global Select Market of $36.75 on May 30, 2025. For the avoidance of doubt, for the purposes of the exercise of any conversion rights in respect of the Notes, the conversion rate and conversion price will be based on the original principal amount of the Notes, and not the Accreted Principal Amount. The conversion rate and conversion price per original principal amount of Notes will be subject to customary adjustments upon the occurrence of certain events. For conversions made in connection with a “make-whole fundamental change”, as defined in the respective Indentures, the conversion rate will be increased based on a customary make-whole table.

     

    Taking into account the Accreted Principal Amount payable at maturity, the effective conversion price of the 2029 Notes is equal to approximately $61.74 per Class A ordinary share at maturity, implying an effective conversion premium of approximately 68%, and the effective conversion price of the 2031 Notes is equal to approximately $64.31 per Class A ordinary share at maturity, implying an effective conversion premium of approximately 75%.

     

     

     

     

    Prior to the close of business on the business day immediately before the date that is two months prior to the respective maturity date of the Notes, the Notes of such tranche will be convertible only upon satisfaction of certain conditions and during certain periods, including if the sale price of the Class A ordinary shares over a specified period of time is equal to or greater than 130% of the product of the then-applicable conversion price and the ratio of the Accreted Principal Amount at the time to the original principal amount of the Notes (the “Accretion Ratio”). From the date that is two months prior to the respective maturity date of the Notes, the Notes of such tranche will be convertible at any time at the election of the holders of the Notes until the close of business on the second scheduled trading day immediately preceding the respective maturity date. The Company will settle conversions of the Notes by paying or delivering, as applicable, cash, Class A ordinary shares or a combination of cash and Class A ordinary shares, at the Company’s election, based on the then-applicable conversion rate per original principal amount of Notes.

     

    The Company may elect to redeem the Notes, in whole or in part (subject to certain limitations), for cash on or after December 10, 2026 (approximately 18 months after closing), in the case of the 2029 Notes, and on or after June 10, 2027 (approximately 24 months after closing), in the case of the 2031 Notes, in each case before the 30th scheduled trading day immediately before the respective maturity date, but only if the last reported sale price per Class A ordinary share is equal to or greater than 130% of the product of the then-applicable conversion price and the Accretion Ratio for a specified period of time. The Notes will also be redeemable at the option of the Company following the occurrence of certain tax law changes. The redemption price in each case will be equal to the Accreted Principal Amount at the time of the Notes to be redeemed, plus accrued and unpaid interest, if any, on the original principal amount of such Notes to, but excluding, the redemption date. Following delivery of a redemption notice by the Company, holders of the Notes will have the right, at their option, to convert their Notes prior to the redemption date based on the then-applicable conversion rate per original principal amount of Notes. Such conversions will be settled as described above. No make-whole adjustments to the conversion rate will be made in connection with any optional redemption or tax redemption.

     

    Holders of the Notes have the right to require the Company to repurchase all or a portion of their Notes upon the occurrence of a fundamental change (as defined in the Indentures) at a cash repurchase price of 100% of their respective Accreted Principal Amount at the time, plus accrued and unpaid interest, if any, on the original principal amount of their Notes to, but excluding, the applicable repurchase date.

     

    The Notes have been sold only to investors who are “qualified institutional buyers” as defined in Rule 144A under the Securities Act.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      NEBIUS GROUP N.V.
         
    Date: June 5, 2025 By: /s/ Boaz Tal
        Boaz Tal
        General Counsel

     

     

     

    Get the next $NBIS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NBIS

    DatePrice TargetRatingAnalyst
    1/15/2026$126.00Equal-Weight
    Morgan Stanley
    11/19/2025$175.00Mkt Outperform
    Citizens JMP
    9/15/2025Neutral
    Seaport Research Partners
    7/14/2025$68.00Buy
    Goldman
    6/5/2025$84.00Buy
    Arete
    5/6/2025$34.00Outperform
    Northland Capital
    2/25/2025$50.00Buy
    DA Davidson
    2/24/2025$51.00 → $60.00Buy
    BWS Financial
    More analyst ratings

    $NBIS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nebius Group N.V. Announces Date of Fourth Quarter and Full Year 2025 Results and Conference Call

    Nebius Group N.V. (("Nebius Group" or the "Company", NASDAQ:NBIS) will release its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, before market open. Nebius Group will also hold a conference call to discuss its results at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time / 2:00 p.m. Central European Time) on the same day. The registration link to access the webcast and its replay will be available on Nebius Group's Investor Relations website at https://nebius.com/investor-hub. About Nebius Group Nebius Group (NASDAQ:NBIS) is a technology company building full-stack infrastructure for the global AI industry. Headquartered in Amsterdam and listed on Nas

    2/2/26 2:39:00 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    Tradr Rolls Out Short Leveraged ETFs on APLD, IREN, LCID & NBIS

    Funds seek 200% inverse daily exposure on Applied Digital, IREN, Lucid and Nebius stock NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, today launched four new short leveraged ETFs on single stocks. The Cboe-listed funds seek to deliver the inverse of twice (-200%) the daily performance of a specific underlying stock. The following ETFs are expected to open for trading today: Tradr 2X Short APLD Daily ETF (Cboe: APLZ) – tracks Applied Digital Corporation (NASDAQ:APLD)Tradr 2X Short IREN Daily ETF (Cboe: IREZ) – tracks IREN Limited (NASDAQ:IREN)Tradr 2X Short LCID Daily ETF (Cboe: LCIZ) – tracks Lucid Group

    1/22/26 6:46:00 AM ET
    $APLD
    $IREN
    $LCID
    Finance: Consumer Services
    Finance
    EDP Services
    Technology

    Nebius to Offer NVIDIA Vera Rubin NVL72 in US and Europe From H2 2026

    Nebius will be among the first NVIDIA Cloud Partners to bring the next-generation accelerated computing platform to market Nebius (NASDAQ:NBIS) will deploy the NVIDIA Rubin platform through Nebius AI Cloud and Nebius Token Factory, unlocking next-generation reasoning and agentic AI capabilities for customers starting H2 2026. Nebius, an NVIDIA Cloud Partner, will be among the first AI cloud providers to offer NVIDIA Vera Rubin NVL72. Nebius will integrate Vera Rubin NVL72 across its full-stack infrastructure at data centers in the US and Europe, enabling customers to build next-generation AI applications with regional availability and control. Launched at CES 2026, Vera Rubin NVL72

    1/6/26 5:54:00 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    $NBIS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Morgan Stanley initiated coverage on Nebius Group N.V. with a new price target

    Morgan Stanley initiated coverage of Nebius Group N.V. with a rating of Equal-Weight and set a new price target of $126.00

    1/15/26 8:38:40 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    Citizens JMP initiated coverage on Nebius Group N.V. with a new price target

    Citizens JMP initiated coverage of Nebius Group N.V. with a rating of Mkt Outperform and set a new price target of $175.00

    11/19/25 8:57:24 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    Seaport Research Partners initiated coverage on Nebius Group N.V.

    Seaport Research Partners initiated coverage of Nebius Group N.V. with a rating of Neutral

    9/15/25 8:09:01 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    $NBIS
    SEC Filings

    View All

    SEC Form 144 filed by Nebius Group N.V.

    144 - Nebius Group N.V. (0001513845) (Subject)

    12/30/25 9:33:06 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Nebius Group N.V.

    SCHEDULE 13G/A - Nebius Group N.V. (0001513845) (Subject)

    11/14/25 12:37:21 PM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    SEC Form 6-K filed by Nebius Group N.V.

    6-K - Nebius Group N.V. (0001513845) (Filer)

    11/13/25 7:01:49 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    $NBIS
    Leadership Updates

    Live Leadership Updates

    View All

    Marc Boroditsky Joins Nebius as Chief Revenue Officer

    Nebius (NASDAQ:NBIS), a leading AI infrastructure company, today announced the appointment of Marc Boroditsky as Chief Revenue Officer as the company continues to build out its global sales team. A seasoned senior tech executive, Marc has a strong global go-to-market track record of driving high growth – in five years at Twilio he grew paying customers six times, and revenue more than 10 times to $4 billion. Previously he founded several successful companies, and served as a senior leader at Oracle and most recently Cloudflare. Arkady Volozh, founder and CEO of Nebius, welcomed Marc to the company: "We are building a global company and planning to grow many times in the coming years.

    5/28/25 7:30:00 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    $NBIS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Nebius Group N.V.

    SC 13G/A - Nebius Group N.V. (0001513845) (Subject)

    11/12/24 10:32:14 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    $NBIS
    Financials

    Live finance-specific insights

    View All

    Nebius Group N.V. Announces Date of Fourth Quarter and Full Year 2025 Results and Conference Call

    Nebius Group N.V. (("Nebius Group" or the "Company", NASDAQ:NBIS) will release its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, before market open. Nebius Group will also hold a conference call to discuss its results at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time / 2:00 p.m. Central European Time) on the same day. The registration link to access the webcast and its replay will be available on Nebius Group's Investor Relations website at https://nebius.com/investor-hub. About Nebius Group Nebius Group (NASDAQ:NBIS) is a technology company building full-stack infrastructure for the global AI industry. Headquartered in Amsterdam and listed on Nas

    2/2/26 2:39:00 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    Nebius Group N.V. announces date of third quarter 2025 results and conference call

    Nebius Group N.V. (("Nebius Group" or the "Company", NASDAQ:NBIS) will release its third quarter 2025 financial results on Tuesday, November 11, 2025, before market open. Nebius Group will also hold a conference call to discuss its results at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time / 2:00 p.m. Central European Time) on the same day. The registration link to access the webcast and its replay will be available on Nebius Group's Investor Relations website at https://nebius.com/investor-hub. About Nebius Group Nebius Group (NASDAQ:NBIS) is a technology company building full-stack infrastructure for the global AI industry. Headquartered in Amsterdam and listed on Nasdaq, Nebius Grou

    10/22/25 8:23:00 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    Report Highlights Growth in AI Biomarker Monitoring as Industry Giant's GPUs Power Next-Gen Platform

    MarketNewsUpdates News Commentary NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The global Diagnostic Biomarker market is experiencing unprecedented growth and is projected to continue to see substantial growth in years to come. A recent report from the (NIH) National Library of Medicine discussed the AI-Assisted Biomarker, said that: "Recently, advancements in healthcare digitization and personalized treatments have led to groundbreaking developments. Utilization of AI and ML has the potential to enhance comprehension of disease onset and progression, potentially uncovering new disease subtypes, unveiling novel drug targets, advancing the field of precision medicine, propelling efforts towards d

    9/11/25 8:45:00 AM ET
    $APLD
    $NBIS
    $NVDA
    Finance: Consumer Services
    Finance
    Computer Software: Programming Data Processing
    Technology